Attention deficit-hyperactivity disorder and its deceivers

Current Problems in Pediatrics

Volumn 30, Issue 2, 2000, Pages 41-50

  Buttress, Susan ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; CHILD; DIFFERENTIAL DIAGNOSIS; HUMAN; MENTAL DISEASE; REVIEW; SENSORY DYSFUNCTION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; MENTAL DISORDERS; SENSATION DISORDERS;

EID: 0034132890     PISSN: 00459380     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0045-9380(00)80044-4     Document Type: Article

References (31)

1. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry 1937;94:577-85.
2. Wender PH. Minimal brain dysfunction in children. New York: Wiley Interscience; 1971.
3. Silver L. Controversial approaches to treating learning disabilities and attention deficit disorder. Am J Dis Child 1986;140:1045-52.
4. Shaywitz S, Shaywitz B. Attention deficit disorder: current perspectives. Pediatric Neurol 1987;3:129-35.
5. Barkley RA. Predicting the response of hyperkinetic children to stimulant drugs: a review. J Abnorm Child Psychol 1976;4:327-48.
6. Taylor E, Schachar R, Thorley G, Wieselberg M, Everitt B, Rutter. Which boys respond to stimulant medication? A consistent trial of methylphenidate in boys with disruptive behavior. Psychol Med 1987;17:121-43.
7. Biederman J, Faerone SV, Mick E, et al. Attention deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 1996; 35:997-1008.
8. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;48:564-77.
9. Taylor E, Chadwick O, Hepinstall E, et al. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry 1996;35:1213-26.
10. Biederman J, Wilens T, Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997;36:21-9.
11. Shaywitz B, Shaywitz S. Comorbidity: a critical issue in attention deficit disorder. J Child Neurol 1991;6(suppl):S 13-20.
12. Spencer T, Biederman J, Wiliness T, et al. Pharmacotherapy of attention deficit hyperactivity disorders across the life cycle, J Am Acad Child Adolesc Psychiatry 1996;35:409-32.
13. Weinberg W, Brumback R. The myth of attention deficit hyperactivity disorder: symptoms resulting from multiple causes. J Child Neurol 1992;7:431-46.
14. Goldman L, Genel M, Bezman R, Slanetz P. Diagnosis and treatment of attention- deficit/hyperactivity disorder in children and adolescents. JAMA 1998;279:1100-7.
15. Esser G, Schmidt MH, Woerner W. Epidemiology and course of psychiatric disorders in school-age children: results of a longitudinal study. J Child Psychol Psychiatry 1990;31:243-63.
16. Bosco JJ, Robin SS. Hyperkinesis: prevalence and treatment. In: Whalen CK, Render B, editors. Hyperactive children. New York: Academic Press; 1980. p. 173.
17. Miller RG, Palkes HS, Stewart M. Hyperactive children in suburban elementary schools. Child Psychiatry Hum Dev 1973;4:121.
18. Nass R. Etiologies of attention deficit hyperactivity disorder: facts and myths. Int Pediatr 1995;10:226-41.
19. Shaywitz SE, Cohen PM, Cohen JE, et al. Long-term consequences of Reye syndrome: a sibling-matched, controlled study of neurologic, cognitive academic and psychiatric function. J Pediatr 1982; 100:41.
20. Pauls DL, Shaywitz SE, Kramer PL, et al. Demonstration of vertical transmission of attention deficit disorder. Ann Neurol 1983;14:363.
21. Levy F, Hay DA, McStephen S, Wood C, Waldman I, et al. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997;36:737-44.
22. Cantwell DP. Psychiatric illness in the families of hyperactive children. Arch Gen Psychiatry 1972,27:414-7.
23. Weiss G, Minde K, Werry J, et al. Studies on the hyperactive child, viii: five year follow-up. Arch Gen Psychiatry 1971;21:409-14.
24. Evans RW, Gualtieri CT, Hicks RE. A neuropathic substrate for stimulant drug effects in hyperactive children. Clin Neuropharmacol 1986;9:264-81.
25. Castellanos X. Neuroimaging of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 1997;6:383-411.
26. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. p. 78-85.
27. Sexson S, Dingle A. Medical problems that might present with academic difficulties. Child Adolesc Psychiatr Clin N Am 1997;6:509-22.
28. Weinberger M, Lingren S, Bender B, Lerner J, Szefler S. Effects of theophylline on learning and behavior: reason for concern or concern without reason? J Pediatr 1987; 106:471-5.
29. Rachelefsky G, Wo J, Adelson J, et al. Behavioral abnormalities and poor school performance due to oral theophylline use. Pediatrics 1986;78:1133-8.
30. Streissguth A. Fetal alcohol syndrome: early and long-term consequences. In: Martinez B, editor. Teaching children affected by prenatal drug exposure. Bloomington (IN): Center for Evaluation, Develop, Research, Phi Delta Kappa; 1995. p. 29-33.
31. Zuckerman B, Breshnahan K. Developmental and behavioral consequences of prenatal drug and alcohol exposure. Pediatr Clin North Am 1991;38:1387-1406.